Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Encouraging data for Eisai epilepsy drug

August 24, 2010 Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306

A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …
News

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
News

Greece set for further price cuts

August 23, 2010 Sales and Marketing Greece

The Greek government is set to impose price cuts of more than 10% and will further cut reimbursement for a …
News

Hospital consultants’ bonuses to be reviewed

August 23, 2010 Sales and Marketing NHS, consultants

NHS consultants could soon be among those to feel the sting of government cutbacks, according to the secretary of state …
News
Roche

Roche to acquire digital pathology specialists

August 23, 2010 Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
News

Pharma sector a ‘market for lemons’

August 20, 2010 Sales and Marketing NICE, health economics

  American sociologist Donald Light has made a provocative assessment of the pharma industry, saying the industry is able to exaggerate …
News

Benlysta to be fast-tracked by FDA

August 20, 2010 Sales and Marketing Benlysta, GSK, HGS, Lupus

 New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …
News

Kowa launches new statin in the UK

August 20, 2010 Sales and Marketing Kowa, Recordati, cv, statin

A new statin has been launched in the UK by Japanese pharma company Kowa.Livazo (pitavastatin) has been approved by the …
News
Rupert Photo

Rupert Potter joins Incuna

August 20, 2010 Medical Communications, Sales and Marketing Incuna, appointment, medical communications, sales and marketing

Rupert Potter has been appointed sales director at digital agency Incuna, where he will be responsible for a number of key …
Appointment
melanoma

BMS’ melanoma drug given priority review

August 19, 2010 Sales and Marketing BMS, ipilimumab

Bristol-Myers Squibb’s promising new treatment for skin cancer melanoma has been given a priority review by the FDA. The company …
News
FDA

FDA already notified on ProAmatine withdrawal, says Shire

August 18, 2010 Sales and Marketing FDA, ProAmatine, Shire

Shire is to withdraw its product ProAmatine following a demand from the FDA early this week regarding post-marketing data on …
News

FDA considers pulling ProAmantine

August 17, 2010 Sales and Marketing FDA, Shire, post-marketing

Shire’s low blood pressure drug ProAmantine and generic copies could be withdrawn from the US market because no post-marketing studies …
News
AZ

AstraZeneca staff to strike over pension cuts

August 17, 2010 Sales and Marketing AstraZeneca, pensions

AstraZeneca is reviewing its position after UK trade union members at the company voted to strike over cuts to pension …
News
EMAWEB

Patient group sponsorship and transparency criticised

August 16, 2010 Sales and Marketing EMA, ethics, patient groups, transparency

High rates of sponsorship from pharma groups for patient groups have been criticised in a new report. The report from …
News

Merck signs Alzheimer’s deal with Alectos

August 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026